Bavarian Nordic, Acambis Settle Smallpox Fight

Law360, New York (July 26, 2007, 12:00 AM EDT) -- Bavarian Nordic and Acambis have settled a global patent feud over a smallpox vaccine, ending a fight that has lasted at least two years, the two companies said Wednesday.

Under the agreement, Denmark-based Bavarian Nordic will grant a license to some Modified Vaccina Ankara-based patents in exchange for an “undisclosed upfront payment” from Acambis.

U.K.-based Acambis will also make royalty and milestone payments if it develops or commercializes certain MVA products in the future, the companies said. Other terms of the agreement are confidential.

MVA halts...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.